Welcome to our dedicated page for Gyrodyne SEC filings (Ticker: GYRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
From Flowerfield’s 63-acre entitlement push to the Cortlandt Manor medical park leases, Gyrodyne’s story is documented in its SEC filings. Investors searching “Gyrodyne insider trading Form 4 transactions” or “Gyrodyne quarterly earnings report 10-Q filing” usually want clarity on how each zoning decision, lease renewal, or rights offering impacts land value and potential liquidating distributions. Unfortunately, those answers sit in dense 8-Ks about planning board meetings or 200-page 10-Ks packed with fair-value tables—enough complexity to make even seasoned professionals ask for “Gyrodyne SEC filings explained simply.”
Stock Titan supplies that simplicity. Our AI parses every submission the moment it hits EDGAR—whether it’s a subscription-rights prospectus or “Gyrodyne Form 4 insider transactions real-time”—and turns it into short, plain-English briefs. With comprehensive coverage of all filing types, you gain instant context: “Gyrodyne earnings report filing analysis” links NOI changes to entitlement spending, while alerts surface lease expirations buried inside exhibits. The result? “Understanding Gyrodyne SEC documents with AI” becomes a workflow, not a wish.
Dig deeper when you need to. The “Gyrodyne annual report 10-K simplified” tracks parcel-level valuation swings; 10-Qs reveal entitlement costs quarter by quarter; the proxy shows “Gyrodyne proxy statement executive compensation” after the Star Equity accord; Forms 4 capture “Gyrodyne executive stock transactions Form 4.” And when a zoning approval drops, our engine tags the “Gyrodyne 8-K material events explained,” delivering real-time insights you can act on. Stop scanning PDFs—use Stock Titan to monitor cash-flow trends, compare segment yields, and make informed decisions faster.
Gyrodyne (GYRO) reported Q3 2025 results under the liquidation basis. Net assets in liquidation were $32,378,669, up from $30,596,313. Based on 2,199,308 shares outstanding, this equates to estimated liquidating distributions of $14.72 per share versus $13.91 at year-end 2024.
The quarter reflects a signed, contingent sale contract for approximately 49 acres at Flowerfield: the B2K Agreement at a purchase price between $24,000,000 and $28,740,000, with management estimating $28,740,000 subject to subdivision and site plan approvals. The investigation period was extended to December 5, 2025. Management continues to target completing liquidation in 2027.
On the balance sheet, real estate held for sale was $54,890,000, cash and cash equivalents $5,106,711, loans payable $10,945,203, and estimated liquidation and operating costs net of estimated receipts $12,273,245. The Company notes available cash resources sufficient to fund operations for approximately 18 months absent additional asset sales. Litigation on the Flowerfield subdivision advanced with prior dismissal of the petition and ongoing appeals, while a cooperation agreement with Star Equity limits proxy activity through specified dates.
Gyrodyne, LLC reported voting results from its 2025 annual meeting. Shareholder participation was 66.50% of the 2,199,308 shares eligible to vote.
Richard B. Smith was elected to a three-year term with 1,394,282 votes for, 29,759 withheld, and 38,531 broker non-votes. Shareholders approved the non-binding advisory vote on named executive officer compensation with 1,392,477 for, 31,202 against, 362 abstain, and 38,531 broker non-votes. Shareholders also ratified Baker Tilly US, LLP as the independent public accounting firm for fiscal 2025 with 1,438,045 for, 284 against, and 24,243 abstain.
Gyrodyne, LLC (GYRO) furnished a Regulation FD update, noting that its President and CEO Gary Fitlin delivered prepared remarks at the 2025 Annual Shareholders Meeting held on November 5, 2025. The text of the remarks is included as Exhibit 99.1 and incorporated by reference.
The company states that the information provided under Item 7.01, including Exhibits 99.1 and 99.2, is furnished and not deemed filed under the Exchange Act, and therefore not subject to Section 18 liabilities.
Gyrodyne, LLC (GYRO) filed its definitive proxy for the 2025 annual meeting. Shareholders will vote on November 5, 2025 at 11:00 a.m. ET in Saint James, NY.
The agenda includes: (1) elect one director for a three-year term, with the Board nominating Richard B. Smith; (2) a non-binding advisory vote to approve executive compensation; and (3) ratification of Baker Tilly US, LLP as independent auditor for the fiscal year ending December 31, 2025. The Board unanimously recommends voting FOR all proposals.
The record date is September 15, 2025. Shares outstanding and entitled to vote were 2,199,308 as of the record date. Gyrodyne entered a cooperation agreement with Star Equity Fund, LP, under which Star Equity withdrew its nominations and agreed to certain standstill and voting commitments; the Company will nominate one director and reduce the Board to four directors.
Gyrodyne, LLC entered into governance agreements with Star Equity Fund and Leap Tide Capital to resolve proxy matters and align voting. Star Equity withdrew its June 4, 2025 nomination notice and agreed to vote its shares in line with the Board’s recommendations until December 31, 2026, or December 31, 2027 if both Nader G.M. Salour and Jan H. Loeb are re-nominated for 2026 and accept. Limited exceptions permit discretionary voting on certain extraordinary transactions and following ISS recommendations at a special meeting after the Annual Meeting.
Gyrodyne will nominate only Richard B. Smith for a new three‑year term at the 2025 Annual Meeting and reduce the Board from five to four directors, with a defined process for a mutually acceptable independent replacement if a continuing director departs. The Company capped aggregate Chairman fees at $65,000 and established mutual non‑disparagement through the Termination Date. The Leap Tide agreement adds coordinated voting and customary standstill through the lead‑up to the 2028 nomination window.
Gyrodyne, LLC (GYRO) Form 4 summary: Towerview LLC reported an insider sale on 09/08/2025. The filing shows a disposition of 1,973 common shares at a price of $12.55 each. After the sale, the reporting person beneficially owns 338,107 common shares. The transaction is coded S (sale) and the ownership form is reported as Direct (D). The Form 4 was signed by Daniel R. Tisch.
Gyrodyne, LLC urges shareholders to use the WHITE universal proxy card to vote FOR the company nominees Paul L. Lamb and Richard B. Smith on Proposal 1, FOR the non‑binding advisory approval of executive compensation on Proposal 2, and FOR ratification of Baker Tilly as the independent registered public accounting firm for the fiscal year ending December 31, 2025. The filing warns shareholders not to sign or return any proxy card or voting instruction form sent by or on behalf of Star Equity because only the latest dated proxy will be counted. Because Star Equity has nominated director candidates, the election is contested and a universal proxy card will be used; shareholders may vote for nominees from either slate but may not vote for more nominees than seats available.
Gyrodyne, LLC director Ronald J. Macklin filed an amended Form 4 showing an insider transaction dated 03/12/2024. The filing reports the acquisition of 8,698 common shares through exercise of rights in a rights offering at a price of $8 per share, and records 30,441 shares beneficially owned following the transaction. The amendment corrects the number of shares acquired and the number beneficially owned as noted in the filing. The document is an amended disclosure of previously reported insider activity.
Star Equity Fund and affiliated parties report beneficial ownership of 156,774 shares of Gyrodyne, LLC, representing approximately 7.13% of the outstanding common stock based on 2,199,308 shares outstanding as of August 8, 2025. The filing is Amendment No. 7 to a Schedule 13D and states the Reporting Persons filed jointly under a Joint Filing Agreement dated August 22, 2025. The group includes Star Equity Fund, Star Equity GP, Star Investment Management, Star Operating Companies, Star Value, Hudson Global, CEO Jeffrey E. Eberwein, and nominees Hannah M. Bible and Matthew R. Sullivan. The filing confirms sole voting and dispositive power over the 156,774 shares by the named reporting entities and discloses no recent transactions for most reporting persons within the past 60 days, with Star Equity Funds recent trades referenced in an attached Schedule A.
Amendment No. 2 to Schedule 13G updates the ownership disclosure for Gyrodyne, LLC. The filing reports that Neil S. Subin beneficially owns 107,188 Common Shares, representing 4.9% of the outstanding class based on 2,199,308 shares. The Amendment states Mr. Subin has ceased to be the beneficial owner of more than 5% of the Common Shares and constitutes an exit filing. The filing also notes Mr. Subin's roles as President and Manager of MILFAM LLC and trustee for certain Miller family trusts, which relate to his management and trustee relationships to entities holding securities.
FAQ
What is the current stock price of Gyrodyne (GYRO)?
What is the market cap of Gyrodyne (GYRO)?
